In the last few years there has been an increasing interest in studying the biology of the dimorphic fungus Sporothrix schenckii, and particular attention has been focused on its molecular phylogeny which has undoubtedly improved our knowledge of the taxonomy, and most importantly, of the epidemiology of this pathogenic fungus.
Currently, S. schenckii is recognized as a cryptic species complex that includes six phylogenetically closely related species, most of which are capable of causing serious life-threatening infections in humans and other animals.
For decades, researchers around the world have reported differences in virulence among S. schenckii isolates but in light of recent taxonomic changes that have affected this species, the question of whether the observed striking variability is really due to different isolates of the same species or whether it is attributable to different species of the cryptic complex remains speculative and unresolved. A compelling response to this question comes from a recent research, published in this issue of Virulence, which reports new insights into virulence profiles, immunogenicity and protein secretion in S. schenckii sensu stricto isolates.
The dimorphic fungi comprise a group of important human pathogens and represent a family of seven phylogenetically related ascomycetes that include Blastomyces dermatitidis, Coccidioides immitis, Coccidioides posadasii, Histoplasma capsulatum, Paracoccidioides brasiliensis, Penicillium marneffei and Sporothrix schenckii.1 These primary pathogens possess the unique ability to switch between two different morphologies (mold and yeast) in response to thermal stimuli. In the environment, they grow as mold that produces conidia or infectious spores which, when transmitted to humans or other susceptible mammalian hosts, are capable to convert into pathogenic yeasts causing serious life-threatening infections.1
Over the last few years, S. schenckii has received particular attention due the increased number of infections caused by it worldwide. Taxonomically, this species belongs to the phylum Ascomycota, order Ophiostomatales, family Ophiostomataceae and it has largely been known as the etiological agent of sporotrichosis, a cutaneous, subcutaneous or a systemic mycosis that affects humans and other mammals.2
Despite the existence of the fungus worldwide, infections due to S. schenckii are more common in certain geographical areas such as tropical and subtropical regions.2,3 Many South American countries (especially Brazil, Peru, Colombia and Uruguay) including Mexico, South Africa, India and Japan are considered endemic regions for sporotrichosis.4 In addition, a particular geographical area called Abancay, in the south central Peruvian highlands, showed a relatively high prevalence of this disease and is considered to be a hyperendemic area with an estimated incidence of approximately 50–60 cases per 100,000 inhabitants per year.4 However, although now it is considered a rare or sporadic mycosis, sporotrichosis was also a common disease in France in 1900;2 it declined after two decades and today intermittently appears in some European countries. In 2009, an autochthonous case was reported in France,5 and several others have been described in Italy,6-8 Spain,9 Portugal,10 United Kingdom11 and Turkey.12 Such data indicate that sporotrichosis is more widespread in European countries than was previously thought and S. schenckii could represent a re-emerging pathogen in the future.
As the fungus is abundant in soil, wood and moss, most infections occur following minor skin trauma in people with occupations or hobbies involving the outdoors such as gardening, farming, hunting or other activities that entail contact with vegetation. Similarly, inoculation may also occurs after motor vehicle accidents and in laboratory personnel handling Sporothrix-infected specimens.2,13
Despite the increased incidence of sporotrichosis observed in the last few years and the worldwide distribution of the fungus,2,14,15 the study of this microrganism is still in its infancy and very little is known about its basic biology including genetics, virulence, pathogenicity and immune modulation of the host. However, a particular attention has recently been focused on the study of its biology at molecular level and a special emphasis has been given to molecular phylogeny which has significantly improved our knowledge of the its taxonomy and biodiversity. Results gained from these studies have confirmed the initial assumption that more species could be present within S. schenckii population.16 In fact currently, S. schenckii is recognized as a cryptic species complex including Sporothrix brasiliensis, Sporothrix globosa, Sporothrix mexicana, Sporothrix luriei, Sporothrix pallida (formerly Sporothrix albicans) and S. schenckii\ sensu stricto.11,17,18 All these species share many genetic and phenotypic characteristics with S. schenckii and they are, therefore, easily misidentified as such by conventional methods of identification. This limits our understanding of their epidemiology and consequently their clinical significance is still little known. However, except for S. pallida, the other Sporothrix species have been reported to cause sporotrichosis in humans and other animals.2,10,11,19,20 In particular it has been recently reported that S. mexicana and S. globosa were present in clinical collections since 1955.15 In addition, the few data published so far have clearly shown that the geographic distribution of these fungi as well as their virulence, pathogenicity and trends in antifungal susceptibilities are variable11,21,22 and some species, such as S. brasiliensis and S. mexicana, appear to be almost exclusively restricted to certain geographic areas.11,15
In past years, using mammalian animal models, several research groups have studied the effect of infection caused by S. schenckii without taking into account the occurrence of its phylogenetically closely related relatives with reduced or absent pathogenicity.23-28 Such studies have demonstrated variation in virulence levels among different S. schenckii isolates although the lack of proper species identification could have led to erroneous conclusions regarding the pathogenicity of this species.21,28 In fact more recent studies have reported that not all the members of S. schenckii complex are equally likely to cause infections in mice and some of them, especially clade I strains, today known as S. brasiliensis,11 are particularly virulent, spread rapidly to other organs such as liver, kidneys, and brain and cause more severe infections than other Sporothrix species.21 Therefore it is not yet well-known whether the striking variability in virulence, previously observed for S. schenckii, is really due to different isolates of the same species or whether it is attributable to different species of the cryptic complex. However, this question was initially addressed in 2009 when different levels of virulence were reported among the diverse species of the complex.21 In that comparative study, S. brasiliensis was the most virulent and pathogenic species followed by S. schenckii sensu stricto, S. globosa, S. mexicana and avirulent species S. pallida.21 Subsequently was evaluated the virulence of S. luriei in a murine model of disseminated infection and even though only one strain was tested, the obtained results indicated that the level of virulence displayed by this species is comparable to that of S. brasiliensis and or S. schenckii.29 However, a comprehensive comparative study on virulence, using a number of S. schenckii sensu stricto isolates, has never been performed before and therefore, in light of recent taxonomic changes that have affected this species, the question of whether different isolates of S. schenckii sensu stricto have similar levels of virulence, or not, remains purely speculative.
Putting together all these observations it is easy to capture the originality of the study of Fernandes et al.30 published in this issue of Virulence. This study, performed using a number of S. schenckii sensu stricto isolates including S. brasiliensis and S. globosa, reports new data on virulence of these Sporothrix species and also evaluates protein secretion and immunogenicity of these pathogenic fungi.
One important aspect of this study is that the fungal strains used were initially identified using phenotypic and molecular methods according to recent studies.11,30 Interestingly, based on partial sequencing of the calmodulin-encoding gene, Fernandes et al.30 described one intriguing isolate that although it was identified as S. schenckii, it was also unable to assimilate sucrose, a disaccharide that is, typically, not assimilated by S. brasiliensis and S. luriei and it is, therefore, often used as phenotypic marker to presumptively differentiate these fungi from all other sucrose-positive species of the cryptic complex.11,18 This indicates that phenotypic methods should be used with caution in the identification of the Sporothrix species and that molecular methods should be always employed.
One other remarkable aspect of the work of Fernandes and colleagues30 is that their results confirm the existence of different virulence profiles in S. schenckii sensu stricto isolates. In particular, based on survival times of infected BALB/c mice and fungal tissue burden, the authors observed a great deal of heterogeneity of virulence which allowed them to classify the fungal isolates in four discrete groups: highly, medium-, low- and non-virulent.30 Nevertheless, although two S. schenckii isolates were considered as “highly virulent,” they were less virulent than S. brasiliensis used as control thereby reinforcing the initial assumption that this latter species is the most pathogenic among all those belonging to the cryptic complex.21 However, according to previous studies of Fernandes et al.31 the authors also found that one of the “highly virulent” S. schenckii isolates shows a number of secreted enzymes (proteinase, caseinase, gelatinase, DNase and urease) most of which were not observed in the hypervirulent species S. brasiliensis.30 This indicates that the mechanisms promoting pathogenesis are much more complex, perhaps not conserved among closely related Sporothrix species and probably involve different virulence factors to evade the host immune system.
The immunological mechanisms implicated in the prevention and control of sporotrichosis are still not fully understood, but it known that they include both cellular and humoral immune responses.2,32,33 Studies in mice suggested that the cellular response appear to be triggered by surface cell antigens, especially some lipids, that inhibit the phagocytosis process and induce high liberation of tumor necrosis factor-α (TNF-α) and nitric oxide (NO) in macrophage cultures.34 Conversely, the humoral response is induced by secreted proteins, the so-called exoantigens, which are not involved in cellular response.2
One of the major exoantigens detected in the cell wall of both morphologies of S. schenckii is a 70-kDa glycoprotein (gp70) which also functions as an adhesin by mediating the interaction of the fungus with the extracellular matrix protein fibronectin and host tissues.14,35 In the study of Fernandes et al.30 the protein profiles of exoantigens obtained from S. schenckii, S. brasiliensis, and S. globosa isolates were rather heterogeneous with two principal molecules (60 and 46 kDa) secreted by all examined isolates. However in spite of being commonly produced these antigens were not always recognized by respective antisera obtained from infected mice. In particular the 60-kDa antigen was immunogenic only with antisera obtained using virulent isolates of S. schenckii, including S. brasiliensis, whereas it was not recognized by antisera from non-virulent isolates and S. globosa.30 In addition, one S. schenckii, classified as “medium virulent” isolate, secreted the 60-kDa molecule but the antigen was not recognized by the corresponding antiserum indicating that most likely the antigenicity of this molecule varies in relation to the post-translational modifications which can produce isoforms that do not elicit a humoral immune response. On the other hand one other hypothesis that may explain the different behavior of the 60-kDa protein might be related to its expression in different cell types (mold and yeast) or to experimental methods used for producing the antigen and antiserum respectively. In fact a recent study, using 2D-immunoblotting with anti-S. schenckii antibodies, revealed that a 60-kDa antigenic glycoprotein was present only on the surface of yeast-like cells36 and not in mycelial cells as reported instead by Fernandes et al.30 Anyhow, being the immunodominant molecule in the S. schenckii complex, this protein represents a good candidate for further studies on the immunogenicity and pathogenesis of these species.
S. schenckii have always attracted considerable attention because of its intrinsic pathogenic nature, but, in recent years, even more because sporotrichosis has become a significant public global health problem.14 Today we know that this disease is also caused by other recently described Sporothrix species but the study of their basic biology including virulence and pathogenicity is still too limited.
In our opinion, according to the great deal of data reported by Fernandes et al.30 and the advent of high-throughput next generation sequencing technologies, the genome of S. schenckii and its closest relatives should be sequenced in the coming years. In fact it is singular that among seven clinically relevant dimorphic fungi only S. schenckii has not yet sequenced. Comparative genomics and transcriptomics analysis between highly pathogenic Sporothrix species and species with reduced or absent pathogenicity, certainly, will encourage the molecular study of virulence factors involved in pathogenesis and will accelerate the discovery of new proteins for diagnostics, drug targets and vaccines.
Footnotes
Previously published online: www.landesbioscience.com/journals/virulence/article/23467
References
- 1.Klein BS, Tebbets B. Dimorphism and virulence in fungi. Curr Opin Microbiol. 2007;10:314–9. doi: 10.1016/j.mib.2007.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Barros MB, de Almeida Paes R, Schubach AO. Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev. 2011;24:633–54. doi: 10.1128/CMR.00007-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Romeo O, Scordino F, Criseo G. New insight into molecular phylogeny and epidemiology of Sporothrix schenckii species complex based on calmodulin-encoding gene analysis of Italian isolates. Mycopathologia. 2011;172:179–86. doi: 10.1007/s11046-011-9420-z. [DOI] [PubMed] [Google Scholar]
- 4.Bustamante B, Campos PE. Endemic sporotrichosis. Curr Opin Infect Dis. 2001;14:145–9. doi: 10.1097/00001432-200104000-00006. [DOI] [PubMed] [Google Scholar]
- 5.Magand F, Perrot JL, Cambazard F, Raberin MH, Labeille B. Sporotrichose cutanée autochtone française. Ann Dermatol Venereol. 2009;136:273–5. doi: 10.1016/j.annder.2008.09.021. [DOI] [PubMed] [Google Scholar]
- 6.Baroni A, Palla M, Iovene MR, Faccenda F, Aiello FS, Puca RV, et al. Sporotrichosis: success of itraconazole treatment. Skinmed. 2007;6:41–4. doi: 10.1111/j.1540-9740.2007.05665.x. [DOI] [PubMed] [Google Scholar]
- 7.Cafarchia C, Sasanelli M, Lia RP, de Caprariis D, Guillot J, Otranto D. Lymphocutaneous and nasal sporotrichosis in a dog from southern Italy: case report. Mycopathologia. 2007;163:75–9. doi: 10.1007/s11046-006-0086-x. [DOI] [PubMed] [Google Scholar]
- 8.Criseo G, Malara G, Romeo O, Puglisi Guerra A. Lymphocutaneous sporotrichosis in an immunocompetent patient: a case report from extreme southern Italy. Mycopathologia. 2008;166:159–62. doi: 10.1007/s11046-008-9121-4. [DOI] [PubMed] [Google Scholar]
- 9.Ojeda T, Rodríguez-Pichardo A, Suárez AI, Camacho FM. [Sporotrichosis in Seville (Spain)] Enferm Infecc Microbiol Clin. 2011;29:233–4. doi: 10.1016/j.eimc.2010.06.011. [DOI] [PubMed] [Google Scholar]
- 10.Dias NM, Oliveira MM, Santos C, Zancope-Oliveira RM, Lima N. Sporotrichosis caused by Sporothrix Mexicana, Portugal. Emerg Infect Dis. 2011;17:1975–6. doi: 10.3201/eid1710.110737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Marimon R, Cano J, Gené J, Sutton DA, Kawasaki M, Guarro J. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol. 2007;45:3198–206. doi: 10.1128/JCM.00808-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gürcan S, Konuk E, Kiliç H, Otkun M, Ener B. Sporotrichosis, a disease rarely reported from Turkey, and an overview of Turkish literature. Mycoses. 2007;50:426–9. doi: 10.1111/j.1439-0507.2007.01392.x. [DOI] [PubMed] [Google Scholar]
- 13.Kauffman CA. Sporotrichosis. Clin Infect Dis. 1999;29:231–6, quiz 237. doi: 10.1086/520190. [DOI] [PubMed] [Google Scholar]
- 14.López-Romero E, Reyes-Montes MdelR, Pérez-Torres A, Ruiz-Baca E, Villagómez-Castro JC, Mora-Montes HM, et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol. 2011;6:85–102. doi: 10.2217/fmb.10.157. [DOI] [PubMed] [Google Scholar]
- 15.Rodrigues AM, de Hoog S, de Camargo ZP. Emergence of pathogenicity in the Sporothrix schenckii complex. Med Mycol. 2012 doi: 10.3109/13693786.2012.719648. In press. [DOI] [PubMed] [Google Scholar]
- 16.Marimon R, Gené J, Cano J, Trilles L, Dos Santos Lazéra M, Guarro J. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol. 2006;44:3251–6. doi: 10.1128/JCM.00081-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.de Meyer EM, de Beer ZW, Summerbell RC, Moharram AM, de Hoog GS, Vismer HF, et al. Taxonomy and phylogeny of new wood- and soil-inhabiting Sporothrix species in the Ophiostoma stenoceras-Sporothrix schenckii complex. Mycologia. 2008;100:647–61. doi: 10.3852/07-157R. [DOI] [PubMed] [Google Scholar]
- 18.Marimon R, Gené J, Cano J, Guarro J. Sporothrix luriei: a rare fungus from clinical origin. Med Mycol. 2008;46:621–5. doi: 10.1080/13693780801992837. [DOI] [PubMed] [Google Scholar]
- 19.Madrid H, Cano J, Gené J, Bonifaz A, Toriello C, Guarro J. Sporothrix globosa, a pathogenic fungus with widespread geographical distribution. Rev Iberoam Micol. 2009;26:218–22. doi: 10.1016/j.riam.2009.02.005. [DOI] [PubMed] [Google Scholar]
- 20.de Oliveira MM, de Almeida-Paes R, de Medeiros Muniz M, de Lima Barros MB, Galhardo MC, Zancope-Oliveira RM. Sporotrichosis caused by Sporothrix globosa in Rio De Janeiro, brazil: case report. Mycopathologia. 2010;169:359–63. doi: 10.1007/s11046-010-9276-7. [DOI] [PubMed] [Google Scholar]
- 21.Arrillaga-Moncrieff I, Capilla J, Mayayo E, Marimon R, Mariné M, Gené J, et al. Different virulence levels of the species of Sporothrix in a murine model. Clin Microbiol Infect. 2009;15:651–5. doi: 10.1111/j.1469-0691.2009.02824.x. [DOI] [PubMed] [Google Scholar]
- 22.Marimon R, Serena C, Gené J, Cano J, Guarro J. In vitro antifungal susceptibilities of five species of Sporothrix. Antimicrob Agents Chemother. 2008;52:732–4. doi: 10.1128/AAC.01012-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Charoenvit Y, Taylor RL. Experimental sporotrichosis in Syrian hamsters. Infect Immun. 1979;23:366–72. doi: 10.1128/iai.23.2.366-372.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Dixon DM, Duncan RA, Hurd NJ. Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis. J Clin Microbiol. 1992;30:951–4. doi: 10.1128/jcm.30.4.951-954.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Tachibana T, Matsuyama T, Mitsuyama M. Characteristic infectivity of Sporothrix schenckii to mice depending on routes of infection and inherent fungal pathogenicity. Med Mycol. 1998;36:21–7. doi: 10.1080/02681219880000041. [DOI] [PubMed] [Google Scholar]
- 26.Nobre MdeO, Antunes TdeA, de Faria RO, Cleff MB, Fernandes CG, Muschner AC, et al. Differences in virulence between isolates of feline Sporotrichosis. Mycopathologia. 2005;160:43–9. doi: 10.1007/s11046-005-6866-x. [DOI] [PubMed] [Google Scholar]
- 27.Brito MM, Conceição-Silva F, Morgado FN, Raibolt PS, Schubach A, Schubach TP, et al. Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model. Med Mycol. 2007;45:721–9. doi: 10.1080/13693780701625131. [DOI] [PubMed] [Google Scholar]
- 28.Teixeira PA, de Castro RA, Nascimento RC, Tronchin G, Torres AP, Lazéra M, et al. Cell surface expression of adhesins for fibronectin correlates with virulence in Sporothrix schenckii. Microbiology. 2009;155:3730–8. doi: 10.1099/mic.0.029439-0. [DOI] [PubMed] [Google Scholar]
- 29.Fernández-Silva F, Capilla J, Mayayo E, Guarro J. Virulence of Sporothrix luriei in a murine model of disseminated infection. Mycopathologia. 2012;173:245–9. doi: 10.1007/s11046-011-9506-7. [DOI] [PubMed] [Google Scholar]
- 30.Fernandes G, dos Santos PO, Rodrigues AM, Sasaki AA, Burger E, de Camargo ZP. Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species. Virulence. 2013;4:241–9. doi: 10.4161/viru.23112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Fernandes GF, Do Amaral CC, Sasaki A, Godoy PM, De Camargo ZP. Heterogeneity of proteins expressed by Brazilian Sporothrix schenckii isolates. Med Mycol. 2009;47:855–61. doi: 10.3109/13693780802713216. [DOI] [PubMed] [Google Scholar]
- 32.Carlos IZ, Sassá MF, da Graça Sgarbi DB, Placeres MC, Maia DC. Current research on the immune response to experimental sporotrichosis. Mycopathologia. 2009;168:1–10. doi: 10.1007/s11046-009-9190-z. [DOI] [PubMed] [Google Scholar]
- 33.Castro VS, Pimentel VC, Da Silva AS, Thomé GR, Wolkmer P, Castro JL, et al. Adenosine deaminase activity in serum and lymphocytes of rats infected with Sporothrix schenckii. Mycopathologia. 2012;174:31–9. doi: 10.1007/s11046-011-9511-x. [DOI] [PubMed] [Google Scholar]
- 34.Carlos IZ, Sgarbi DB, Santos GC, Placeres MC. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand J Immunol. 2003;57:214–20. doi: 10.1046/j.1365-3083.2003.01175.x. [DOI] [PubMed] [Google Scholar]
- 35.Lopes-Bezerra LM. Sporothrix schenckii Cell Wall Peptidorhamnomannans. Front Microbiol. 2011;2:243. doi: 10.3389/fmicb.2011.00243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ruiz-Baca E, Mora-Montes HM, López-Romero E, Toriello C, Mojica-Marín V, Urtiz-Estrada N. 2D-immunoblotting analysis of Sporothrix schenckii cell wall. Mem Inst Oswaldo Cruz. 2011;106:248–50. doi: 10.1590/S0074-02762011000200021. [DOI] [PubMed] [Google Scholar]